Zobrazeno 1 - 10
of 397
pro vyhledávání: ''
Autor:
Mehmet Sitki Copur, Thomas Zusag, Nicholas Lintel, John Allen, Wendel Whitney, Paul Rodriguez, Scott Bell
Publikováno v:
ONCOLOGY. :128-133
Spinal cord compression is a potentially devastating consequence of cancer. Early recognition of the signs and symptoms permit diagnosis prior to the development of irreversible neurological damage. This complication occurs in 5% to 10% of patients w
Autor:
Diana Pettinato, Alfredo Mirandola, Francesca Zanellini, Amelia Barcellini, Marianna Roccio, Francesca Valvo, Ester Orlandi, Angiolo Gadducci, Concetta Laliscia
Publikováno v:
Oncology. 99:65-71
Background and Summary: The management of endometrial cancer, in an ever-older population with considerable comorbidity, remains a challenge for gynecological and radiation oncologists. Key Message: The present paper reviews literature data on treatm
Autor:
Masahiro Noda, Takaaki Arigami, Hiroshi Kurahara, Daisuke Matsushita, Satoshi Iino, Keishi Okubo, Yoshiaki Kita, Yoshikazu Uenosono, Yota Kawasaki, Shigehiro Yanagita, Sumiya Ishigami, Kosei Maemura, Shinichiro Mori, Ken Sasaki, Shoji Natsugoe
Publikováno v:
Oncology. 98:273-279
Objective: Chemotherapy is generally recommended as the first-line standard treatment in patients with liver metastasis from gastric cancer. However, the clinical impact of surgical treatment remains unclear in responders after chemotherapy. The pres
Autor:
Kausar Suleman, Noha Jastaniyah, Tusneem Elhassan, Wafa Alkhayal, Osama Almalik, Ali Hassan Mushtaq, Adher Al-Sayed, Dahish Ajarim, Emaan Haque, Taher Al-Tweigeri, Ahmed Badran
Publikováno v:
Oncology. 98:168-173
Background:There is a paucity of literature examining the impact of timing of surgery after neoadjuvant chemotherapy. Objective:This study aimed to analyze the impact of the time taken to initiate surgical treatment following completion of neoadjuvan
Autor:
Yoshikazu Uenosono, Daisuke Matsushita, Yoshiaki Kita, Shigehiro Yanagita, Shoji Natsugoe, Hiroshi Kurahara, Masahiro Noda, Ken Sasaki, Sumiya Ishigami, Keishi Okubo, Takaaki Arigami, Takao Ohtsuka, Shinichiro Mori
Publikováno v:
Oncology. 98:798-806
Objective: Although chemotherapy has been clinically recommended as the initial treatment for patients with peritoneal dissemination of gastric cancer, poor prognosis has been noted among the same patients. However, the prognostic significance of con
Autor:
Hiroshi Yagi, Hideaki Yahata, Nobuko Yasutake, Kazuo Asanoma, Kaoru Okugawa, Keisuke Kodama, Tatsuhiro Ohgami, Kenzo Sonoda, Masafumi Yasunaga, Shusaku Inoue, Kiyoko Kato, Ichiro Onoyama, Eisuke Kaneki
Publikováno v:
Oncology. 98(12)
Introduction: Adjuvant therapy is usually recommended for patients with intermediate-risk cervical cancer (deep stromal invasion [DSI], lymphovascular space invasion [LVSI], and bulky tumor) after radical hysterectomy. However, we previously reported
Autor:
Gota Saito, Toshiyuki Suzuki, Hiroshi Miyakita, Sotaro Sadahiro, Kazutake Okada, Akira Tanaka, Takeshi Akiba, Hiroshi Yamamuro
Publikováno v:
Oncology. 95:246-250
Objective: The National Comprehensive Cancer Network (NCCN) guidelines recommend local excision and observation as standard treatment for selected patients with clinical T1N0M0 rectal cancer. In patients with pathological T1 (pT1) rectal cancer who r
Autor:
Toshiyuki Suzuki, Hiroshi Miyakita, Gota Saito, Kazutake Okada, Takashi Ogimi, Sotaro Sadahiro, Akira Tanaka
Publikováno v:
Oncology. 94:167-175
Objectives: The histologic response to neoadjuvant chemoradiotherapy (nCRT) has been intimately related to outcomes in locally advanced rectal cancer. Serum carcinoembryonic antigen (CEA) levels change after nCRT and after surgery as compared with be
Autor:
Mariko Doi, Hiroki Yamaue, Ken-ichi Okada, Manabu Kawai, Suguru Yamada, Yoshiaki Murakami, Ippei Matsumoto, Sohei Satoi, Toshio Shimokawa, Seiko Hirono, Masayuki Sho, Hidetoshi Eguchi
Publikováno v:
Oncology. 93:343-346
We conducted a prospective multicenter phase II trial of patients with borderline resectable pancreatic carcinoma to investigate the efficacy of neoadjuvant nab-paclitaxel plus gemcitabine therapy on overall survival (OS). The clinical trial primaril
Autor:
Kenji Tamura, Mayu Yunokawa, Seiko Bun, Yuichi Takiguchi, Takahiro Ebata, Kan Yonemori, Shunichiro Iwasawa, Tatsunori Shimoi, Tsukasa Ishiwata
Publikováno v:
Oncology. 93:177-182
Objective: The aim of this study was to investigate the clinical usefulness of amrubicin therapy for patients with non-gastrointestinal (GI) non-pancreatic extrapulmonary neuroendocrine carcinoma (EP-NEC). Methods: The medical records of patients fro